I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Skarbnik, Alan
67
results:
Search for persons
X
Format
Online (67)
Mediatypes
Articles (Online) (44)
OpenAccess-fulltext (23)
Languages
english (59)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
Lisocabtagene maraleucel in follicular lymphoma: the phase ..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
2
Hypertension treatment for patients receiving ibrutinib: a ..:
Samples, Laura
;
Voutsinas, Jenna
;
Fakhri, Bita
...
Blood Advances. 8 (2024) 9 - p. 2085-2093 , 2024
Link:
https://doi.org/10.1182/..
?
3
Activity of venetoclax in patients with relapsed or refract..:
Kater, Arnon P
;
Arslan, Önder
;
Demirkan, Fatih
...
The Lancet Oncology. 25 (2024) 4 - p. 463-473 , 2024
Link:
https://doi.org/10.1016/..
?
4
Real‐world comparative effectiveness of venetoclax‐obinutuz..:
Ghosh, Nilanjan
;
Manzoor, Beenish S.
;
Fakhri, Bita
...
British Journal of Haematology. , 2024
Link:
https://doi.org/10.1111/..
?
5
An indirect comparison of acalabrutinib with and without ob..:
Kittai, Adam S.
;
Allan, John N.
;
James, Dan
...
Blood Advances. 8 (2024) 11 - p. 2861-2869 , 2024
Link:
https://doi.org/10.1182/..
?
6
Author Correction: Lisocabtagene maraleucel in follicular l..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
7
P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:
Rhodes, Joanna
;
Shadman, Mazyar
;
Lamanna, Nicole
...
HemaSphere. 7 (2023) S3 - p. e96103aa , 2023
Link:
https://doi.org/10.1097/..
?
8
Outcomes among adult recipients of CD19 CAR T-cell therapy ..:
Samples, Laura
;
Sadrzadeh, Hossein
;
Frigault, Matthew
...
International Journal of Cancer Care and Delivery. 3 (2023) Supplement 2 - p. , 2023
Link:
https://doi.org/10.53876..
?
9
Treatment Discontinuation Patterns for Patients With Chroni..:
Shadman, Mazyar
;
Manzoor, Beenish S.
;
Sail, Kavita
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 7 - p. 515-526 , 2023
Link:
https://doi.org/10.1016/..
?
10
P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICA..:
Skarbnik, Alan
;
Kittai, Adam
;
Miranda, Miguel
...
HemaSphere. 7 (2023) S3 - p. e4236347 , 2023
Link:
https://doi.org/10.1097/..
?
11
A matching‐adjusted indirect comparison of acalabrutinib ve..:
Kittai, Adam S.
;
Skarbnik, Alan
;
Miranda, Miguel
...
American Journal of Hematology. 98 (2023) 12 - p. , 2023
Link:
https://doi.org/10.1002/..
?
12
P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CH..:
Lansigan, Frederick
;
A. Eyre, Toby
;
Ghosh, Nilanjan
...
HemaSphere. 7 (2023) S3 - p. e6855326 , 2023
Link:
https://doi.org/10.1097/..
?
13
Venetoclax retreatment of patients with chronic lymphocytic..:
Thompson, Meghan C.
;
Harrup, Rosemary A.
;
Coombs, Catherine C.
...
Blood Advances. 6 (2022) 15 - p. 4553-4557 , 2022
Link:
https://doi.org/10.1182/..
?
14
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN..:
Sharman, Jeff P.
;
Egyed, Miklos
;
Jurczak, Wojciech
...
Leukemia. 36 (2022) 4 - p. 1171-1175 , 2022
Link:
https://doi.org/10.1038/..
?
15
Poster: CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzum..:
Sharman, Jeff P.
;
Egyed, Miklos
;
Jurczak, Wojciech
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S220 , 2021
Link:
https://doi.org/10.1016/..
1-15